Watch this Weeks Episode Saturday at 9am CT
Welcome to Episode 208 of UroNurse! In this milestone episode, host Vic Senese, RN, BSN, FAUNA, is joined by expert guest speaker Leann Johnston, Uro-Oncology Clinical Nurse Specialist (CNS), to dive deep into the current landscape of prostate cancer screening and prostate biopsy protocols in Europe. Prostate cancer remains one of the most prevalent malignancies in men globally, but the clinical approach to early detection, PSA screening, and biopsy criteria varies significantly across borders. European urologic practices—frequently guided by the European Association of Urology (EAU) guidelines—have paved the way for innovative screening strategies, including risk-stratified screening, widespread utilization of pre-biopsy multiparametric MRI (mpMRI), and a significant clinical shift from transrectal (TRUS) to transperineal prostate biopsies to minimize sepsis risks. Whether you are a urology nurse, nurse practitioner, physician assistant, urologist, or healthcare student, this comprehensive discussion delivers evidence-based insights to help you understand international standards and advance your clinical practice.
What You'll Learn in This Episode:
Don't miss this milestone episode packed with real-world clinical education, comparative healthcare insights, and actionable knowledge for the entire urological care team.
*The expert's opinions in this communication are personal and not representative of any organization. They are for informational purposes only, not official guidance. Viewers are advised to use their judgment, seek additional advice, and take responsibility for any actions based on these opinions.
Click on image to visit our sponsor's website.
Click below for sponsorship info.
Episode 201: Unraveling the Complexities of cUTI Care: Modernizing cUTI Care with the 2025 IDSA and EAU Updates
CME | CNE | CPE | 1.00 CreditEpisode 196: Opportunistic Pathogens in Healthcare: Hidden Threats Every Nurse Must Know
Click for Contact HoursEpisode 184: Optimizing Urothelial Carcinoma Therapy: From Maintenance to Precision Strategies
1.00 / CME Contact Hour183: Optimizing Care in Advanced Renal Cell Carcinoma: Immunotherapy & Targeted Agents Explained
1.00 / ANCC Contact Hour179: The Future of Prostate Cancer Care: New Treatments Explained for Urology Nurses
1.00 / ANCC Contact HourThe information provided on the site is for educational purposes only, and does not substitute for professional medical advice.
Consult a medical professional or healthcare provider if you are seeking medical advice, diagnoses, or treatment.